Product NDC: | 53808-0311 |
Proprietary Name: | Terazosin Hydrochloride |
Non Proprietary Name: | Terazosin Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Terazosin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53808-0311 |
Labeler Name: | State of Florida DOH Central Pharmacy |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075317 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090701 |
Package NDC: | 53808-0311-1 |
Package Description: | 30 CAPSULE in 1 BLISTER PACK (53808-0311-1) |
NDC Code | 53808-0311-1 |
Proprietary Name | Terazosin Hydrochloride |
Package Description | 30 CAPSULE in 1 BLISTER PACK (53808-0311-1) |
Product NDC | 53808-0311 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terazosin Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20090701 |
Marketing Category Name | ANDA |
Labeler Name | State of Florida DOH Central Pharmacy |
Substance Name | TERAZOSIN HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |